£140.86

Springer Heterocyclic Antitumor Antibiotics - Volume 2

Price data last checked 39 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£141 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 9 days • 9 data points (No recent data available)

Historical
Generating forecast...
£141.63 £140.78 £140.97 £141.15 £141.34 £141.52 £141.71 01 May 2026 03 May 2026 05 May 2026 07 May 2026 09 May 2026

Price Distribution

Price distribution over 9 days • 2 price levels

Days at Price
Current Price
5 days · current 4 days 0 1 3 4 5 £141 £142 Days at Price

Price Analysis

Most common price: £141 (5 days, 55.6%)

Price range: £141 - £142

Price levels: 2 different prices over 9 days

Description

Expand your pharmacological research with Heterocyclic Antitumor Antibiotics: 2, part of the Topics in Heterocyclic Chemistry series by Springer. This specialized academic text provides a deep dive into the synthesis and mechanisms of biologically active compounds. Researchers and medical professionals can explore detailed studies on stilbene and chalcone analogs of Combretastatin, as well as pyrrole natural products with antitumor properties. The volume covers a wide range of critical topics, including the synthesis of carbolines with antitumor activity and the study of diazo and diazonium DNA cleavage agents. It also addresses modern challenges in microbiology, such as the role of beta-lactamase inhibitors in overcoming bacterial resistance and the development of novel synthetic antibacterial agents. This collection serves as a valuable resource for those studying heterocyclic chemistry, drug synthesis, and advanced pharmacology.

Key Features

Comprehensive research on the synthesis of biologically active heterocyclic stilbene and chalcone analogs of Combretastatin.

In-depth analysis of pyrrole natural products and their specific antitumor properties.

Detailed studies on carbolines possessing antitumor activity and their chemical synthesis.

Exploration of diazo and diazonium DNA cleavage agents through model systems and natural product mechanisms.

Examination of novel synthetic antibacterial agents and methods to overcome bacterial resistance.

Expert review of the role of beta-lactamase inhibitors in modern pharmacology.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 November 2010
Listed Since
20 September 2010

Barcode

No barcode data available

Similar Products You Might Like

Chirale Oxazolidin-2-on-Auxiliare auf Kohlenhydratbasis für die stereoselektive Synthese von ß-Lactam- und Aminosäure-Derivaten
96% match

Chirale Oxazolidin-2-on-Auxiliare auf Kohlenhydratbasis für die stereoselektive Synthese von ß-Lactam- und Aminosäure-Derivaten

Vieweg+Teubner Verlag

£76.86 25 Apr 2026
Emerging Targets in Antibacterial and Antifungal Chemotherapy
96% match

Emerging Targets in Antibacterial and Antifungal Chemotherapy

Springer

£101.23 01 Feb 2026
Antimicrobials: Synthetic and Natural Compounds
96% match

Antimicrobials: Synthetic and Natural Compounds

CRC Press

£145.00 12 Jun 2026
Drug Discovery from Natural Products: Volume 25 (Drug Discovery Series)
96% match

Drug Discovery from Natural Products: Volume 25 (Drug Discovery Series)

Royal Society of Chemistry

£70.21 09 Mar 2026
β-Carbolines: A Privileged Scaffold for Modern Drug Discovery
96% match

β-Carbolines: A Privileged Scaffold for Modern Drug Discovery

CRC Press

£129.68 29 Jan 2026
Hydroxamic Acids: A Unique Family of Chemicals with Multiple Biological Activities
96% match

Hydroxamic Acids: A Unique Family of Chemicals with Multiple Biological Activities

Springer

£77.62 02 May 2026
Emerging Targets in Antibacterial and Antifungal Chemotherapy
96% match

Emerging Targets in Antibacterial and Antifungal Chemotherapy

Springer

£148.03 10 Jun 2026
Carbohydrates as Drugs: 12 (Topics in Medicinal Chemistry, 12)
96% match

Carbohydrates as Drugs: 12 (Topics in Medicinal Chemistry, 12)

Springer

£144.97 10 Mar 2026
Antimicrobial Peptides: Methods and Protocols: 618 (Methods in Molecular Biology, 618)
96% match

Antimicrobial Peptides: Methods and Protocols: 618 (Methods in Molecular Biology, 618)

Humana

£73.91 08 Mar 2026
Therapy of Viral Infections: 15 (Topics in Medicinal Chemistry, 15)
96% match

Therapy of Viral Infections: 15 (Topics in Medicinal Chemistry, 15)

Springer

£146.87 12 Apr 2026
Copper in N-Heterocyclic Chemistry
96% match

Copper in N-Heterocyclic Chemistry

Elsevier

£146.99 10 Jun 2026
The Way of Synthesis: Evolution of Design and Methods for Natural Products
96% match

The Way of Synthesis: Evolution of Design and Methods for Natural Products

Wiley

£72.29 18 Apr 2026
Elsevier Isocoumarin and Thiaisocoumarin Chemistry Book
96% match

Elsevier Isocoumarin and Thiaisocoumarin Chemistry Book

Elsevier

£125.79 15 Apr 2026
Medicinal Chemistry of Chemotherapeutic Agents: A Comprehensive Resource of Anti-infective and Anti-cancer Drugs
96% match

Medicinal Chemistry of Chemotherapeutic Agents: A Comprehensive Resource of Anti-infective and Anti-cancer Drugs

Academic Press

£139.79 30 Jan 2026
Bioactive Compounds from Natural Sources: Natural Products as Lead Compounds in Drug Discovery
96% match

Bioactive Compounds from Natural Sources: Natural Products as Lead Compounds in Drug Discovery

CRC Press

£168.97 13 Jun 2026
Coronaviruses and other Novel Antiviral Targets (Volume 57) (Annual Reports in Medicinal Chemistry, Volume 57)
96% match

Coronaviruses and other Novel Antiviral Targets (Volume 57) (Annual Reports in Medicinal Chemistry, Volume 57)

Academic Press

£127.89 30 Apr 2026
Taste and Smell: 23 (Topics in Medicinal Chemistry, 23)
96% match

Taste and Smell: 23 (Topics in Medicinal Chemistry, 23)

Springer

£146.87 13 Apr 2026
Taste and Smell: 23 (Topics in Medicinal Chemistry, 23)
96% match

Taste and Smell: 23 (Topics in Medicinal Chemistry, 23)

Springer

£143.39 10 Mar 2026
Development of New Radical Cascades and Multi-Component Reactions: Application to the Synthesis of Nitrogen-Containing Heterocycles (Springer Theses)
95% match

Development of New Radical Cascades and Multi-Component Reactions: Application to the Synthesis of Nitrogen-Containing Heterocycles (Springer Theses)

Springer

£72.98 08 Mar 2026
Development of New Radical Cascades and Multi-Component Reactions: Application to the Synthesis of Nitrogen-Containing Heterocycles (Springer Theses)
95% match

Development of New Radical Cascades and Multi-Component Reactions: Application to the Synthesis of Nitrogen-Containing Heterocycles (Springer Theses)

Springer

£75.84 27 Feb 2026
Viral Polymerases: Structures, Functions and Roles as Antiviral Drug Targets
95% match

Viral Polymerases: Structures, Functions and Roles as Antiviral Drug Targets

Academic Press

£94.14 25 Apr 2026
Heterocyclic Chemistry, 5th Edition
95% match

Heterocyclic Chemistry, 5th Edition

Wiley

£40.75 27 Jan 2026
The Chemistry of Heterocycles: Nomenclature and Chemistry of Three to Five Membered Heterocycles
95% match

The Chemistry of Heterocycles: Nomenclature and Chemistry of Three to Five Membered Heterocycles

Elsevier

£131.69 05 Feb 2026
Oxazoles, Volume 60, Part A: Synthesis, Reactions, and Spectroscopy (The Chemistry of Heterocyclic Compounds: A Series of Monographs)
95% match

Oxazoles, Volume 60, Part A: Synthesis, Reactions, and Spectroscopy (The Chemistry of Heterocyclic Compounds: A Series of Monographs)

Wiley

£243.20 27 Apr 2026